3Alves G, Forsaa EB, Pedersen KF, et al. Epidemiology of Par- kinson's disease. J Neurol, 2008, 255(Suppl 5) : 18-32.
4Chaudhuri? K R, Odin P, Antonini A, et al. Parkinson's dis- ease: The non-motor issue. Parkinsonism - Related Disorders, 2011, 17(10): 717-723.
5Antonini A, Tesei S, Zecchinelli A, et al. Randomized study of sertraline and low-dose amitriptyline in patients with Parkinson's disease and depression: effect on quality of life. Mov Disord, 2006, 21(8): 1119-1122.
1Wener P, Mytilineou C, Cohen G, et al. Impaired Oxidation action of pyrurate in human embryonic fibroblasts after exposure to Ldopar[J]. Eur pharmacol, 1994, 236(2): 157- 162.
2陈海波 王新德.统一帕金森病评定量表[J].中华老年医学杂志,1999,18(1):61-62.
3Calne DB,Snow BJ,Lee C.Criteria for diagnosing Parkinson's disease.Ann Neurol,1992,32 Suppl:125-127.
4Gelb GJ,Oliver E,Gilman S.Diagnostic criteria for Parkinson's disease.Arch Neurol,1999,56:33-39.
5Gibb WRG.The neuropathology of Parkinson's disease.In:Jankovic J,Tolosa E,eds.Parkinson's disease and movement disorders.Baltimore:Urban and Schwarzenberg,1988.205-223.
6Koller WC.How accurately can Parkinson's disease be diagnosed?Neurology,1992,42Suppl 1:6-16.
8Hughes AJ,Daniel SE,Kilford L,et al.Accuracy of clinical diagnosis of idiopathic Parkinson's disease:a clinico-pathological study of 100 cases.J Neurol Neurosurg Psychiatry,1992,55:181-184.
9The Guideline Review Panel of NICE (the national institute for clinical excellence).Diagnosis and management in primary and secondary care.In Parkinson's disease--full guideline,second consultation,2006.34-38.
10Reijnders JS, Ehrt U, Weber WE, et al. A systematic review of prevalence studies of depression in Parkinson's disease. Mov Dis- ord, 2008, 23(2):183 - 189.
